Ok, I haven't looked at what was said. But this was said 7 days ago.
It should be noted that patients participate in this trial for 12 months. The first
patient commenced in December 2023 and the last patient commenced in August
2024. No patients in the Interim Data have yet completed 12 months of treatment. The trial will therefore not complete until August 2025 and the complete data is only expected in H2 2025. Accordingly, SNT will not know the final outcome of the trial until after that time. While the presentation at the ASH Meeting will provide an update relating to patients at various stages of the trial, the final data may vary
from the Interim Data. Moreover, the trial is not sufficiently advanced to have generated enough data for SNT to approach the FDA on the study design for a pivotal trial – the next milestone in development of the drug.
SNT Price at posting:
6.7¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)